Latest filing published 23 Jun 2026 for Atea Pharmaceuticals, Inc..
No signal scores available.
This profile gathers the share dealings of Bruce Polsky across 2 companies, led by Cogentix Medical Inc /DE/ and Atea Pharmaceuticals, Inc. We count 10 filings; the first trade dates from 20 June 2011 and the latest from 18 June 2026.
Every open-market trade on record is a sale: 1 sale worth €57k. Besides market trades, the filings include 3 share grants and 4 option exercises.
The record was last updated on 23 June 2026 with an option exercise in Atea Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations